Sodium Aescinate
Cerebral Edema
The Second Hospital of Hebei Medical UniversityPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Cerebral Edema cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Conivaptan Jesse Corry | Phase 2 | B |
DEXAMETHASONE Jon Pérez Bárcena | Phase 3 | B |
PANTOPRAZOLE University of Florida | Phase 2 | B |
Famotidine University of Florida | Phase 2 | B |
Glibenclamide Remedy Pharmaceuticals, Inc. | Phase 2 | B |
View all 13 →
Same molecule, other indications
Sodium Aescinate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →